Physician profile
Scott Neusetzer
NPI 1174603757
$6,059.44
in general payments reported to CMS, 2019-2025
42 companies · $1,274 in 2025
The $1,274 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $426 · 2020: $789 · 2021: $947 · 2022: $912 · 2023: $1,006 · 2024: $705 · 2025: $1,274.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,950 · Education: $35.06.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,949.89 |
| Education | $35.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $969.37 | 2019-2025 | Xtandi, Myrbetriq |
| Abbvie INC. | $637.74 | 2019-2025 | |
| Sumitomo Pharma America, INC. | $500.78 | 2023-2025 | Gemtesa, Orgovyx |
| Pfizer INC. | $299.60 | 2019-2025 | |
| Janssen Biotech, INC. | $285.98 | 2019-2025 | Erleada |
| Procept Biorobotics Corporation | $260.62 | 2023 | Aquabeam Robotic System |
| Endo Pharmaceuticals INC. | $214.56 | 2019-2024 | Xiaflex |
| Merck Sharp & Dohme LLC | $195.76 | 2020-2025 | Keytruda, Lynparza |
| Coloplast Corp | $193.21 | 2019-2025 | |
| Allergan, INC. | $192.96 | 2019-2022 | |
| Ferring Pharmaceuticals INC. | $185.99 | 2025 | Adstiladrin |
| Kerecis Limited | $171.68 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Dendreon Pharmaceuticals LLC | $169.05 | 2020-2025 | Provenge |
| Urogen Pharma, INC. | $155.72 | 2020-2025 | Jelmyto |
| Bayer Healthcare Pharmaceuticals INC. | $148.16 | 2019-2024 |
Show all 42 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Accord Healthcare, INC. | $135.22 | 2022-2023 | |
| Teleflex LLC | $116.33 | 2021 | |
| Blue Earth Diagnostics | $115.50 | 2020-2022 | |
| Boston Scientific Corporation | $97.21 | 2021-2023 | Ams 800 Artificial Urinary Sphincter |
| Progenics Pharmaceuticals, INC. | $89.08 | 2022-2025 | Pylarify |
| Olympus America INC. | $85.44 | 2025 | Itind System |
| Myovant Sciences INC. | $77.48 | 2021-2022 | |
| Astrazeneca Pharmaceuticals LP | $77.47 | 2022-2025 | Imfinzi, Lynparza |
| Antares Pharma, INC. | $70.76 | 2020-2022 | |
| Axonics, INC. | $62.38 | 2021-2023 | Bulkamid |
| Laborie Medical Technologies Corp. | $52.99 | 2025 | |
| Urovant Sciences INC | $48.99 | 2021-2022 | |
| Ethicon US, LLC | $45.92 | 2022 | |
| Travere Therapeutics, INC. | $45.83 | 2021 | |
| Tolmar Pharmaceuticals, INC. | $44.71 | 2020-2021 | |
| Photocure INC | $43.79 | 2019 | |
| Hollister Incorporated | $41.44 | 2021-2023 | Infyna Chic |
| Endo USA, INC. | $36.46 | 2024-2025 | Xiaflex |
| Tolmar, INC. | $31.96 | 2023-2024 | |
| Sun Pharmaceutical Industries INC. | $31.52 | 2024-2025 | |
| Novartis Pharmaceuticals Corporation | $30.13 | 2024-2025 | |
| Amgen INC. | $27.60 | 2022 | |
| 180 Medical, INC. | $20.47 | 2023 | Cure Ultra Catheter |
| Medtronic, INC. | $13.99 | 2021 | |
| Clarus Therapeutics INC. | $12.70 | 2021 | |
| Medtronic USA, INC. | $12.60 | 2020 | |
| Civco Medical Instruments | $10.29 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Scott Neusetzer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.